Patents by Inventor Marko Cubrovic

Marko Cubrovic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of an NRTTI compound
    Patent number: 12227536
    Abstract: The present disclosure provides novel anhydrate crystalline Forms 1 and 4 of 4?-Ethynyl-2-fluoro-2?-deoxyadenosine and pharmaceutical compositions thereof, each of which may be useful for the inhibition of HIV reverse transcriptase, the treatment or prophylaxis of HIV infection and/or the treatment, prophylaxis and/or delay in the onset or progression of AIDS or ARC.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: February 18, 2025
    Assignee: Merck Sharp & Dohme LLC
    Inventors: Daniel Skomski, Yongchao Su, Wei Xu, Marko Cubrovic, Stephanie Elizabeth Barrett
  • NOVEL CRYSTALLINE FORMS OF AN NRTTI COMPOUND
    Publication number: 20220056067
    Abstract: The present disclosure provides novel anhydrate crystalline Forms 1 and 4 of 4?-Ethynyl-2-fluoro-2?-deoxyadenosine and pharmaceutical compositions thereof, each of which may be useful for the inhibition of HIV reverse transcriptase, the treatment or prophylaxis of HIV infection and/or the treatment, prophylaxis and/or delay in the onset or progression of AIDS or ARC.
    Type: Application
    Filed: December 16, 2019
    Publication date: February 24, 2022
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Daniel Skomski, Yongchao Su, Wei Xu, Marko Cubrovic